Skip to main content
PMC home page
Cytotechnology logoLink to Cytotechnology
. 2001 Jan;35(1):17–23. doi: 10.1023/A:1008188120766

Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor α

Hiroshi Mano 1,✉, Yoshiyuki Hakeda 3, Masayoshi Kumegawa 3
PMCID: PMC3466614  PMID: 19003277

Abstract

The decrease in estrogen level that follows the onset ofmenopause causes rapid bone loss, resulting in osteoporosis.However, the mechanism remains unclear, especially concerningthe regulation of bone-resorbing osteoclasts. Here we analyzedthe function of estrogen and its receptor in matureosteoclasts. We found that estrogen directly inhibitedbone-resorption by purified rabbit mature-osteoclasts.Moreover, using a RT-PCR technique, we report that nuclearestrogen receptor (ER) α but not ERβ is expressed in mature osteoclasts. The antisense oligodeoxynucleotide for ERα inhibited the reductionin osteoclastic bone-resorbing activity caused by estrogen. We conclude that in part estrogen directly inhibits the bone-resorbing activity of mature osteoclasts through the ERα.

Keywords: estrogen, estrogen receptor, gene expression, osteoclast, osteoporosis, pit assay

Full Text

The Full Text of this article is available as a PDF (105.9 KB).

References

  1. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik JCW, Pols HA, van Leeuwen JP. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology. 1997;138:5067–5070. doi: 10.1210/endo.138.11.5652. [DOI] [PubMed] [Google Scholar]
  2. Blumberg B, Evans RM. Orphan nuclear receptors-new ligands and new possibilities. Gene Dev. 1998;12:3149–3155. doi: 10.1101/gad.12.20.3149. [DOI] [PubMed] [Google Scholar]
  3. Das SK, Taylor JA, Korach KS, Paria BC, Dey SK, Lubahn DB. Estrogenic responses in estrogen receptor-α deficient mice reveal a distinct estrogen signaling pathway. Proc Nat Acad Sci USA. 1997;94:12786–12791. doi: 10.1073/pnas.94.24.12786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hakeda Y, Kumegawa M. The growth and culture of bone cells: Osteoclastic. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. New York: Academic Press; 1996. pp. 1217–1228. [Google Scholar]
  5. Hoshino S, Inoue S, Hosoi T, Saito T, Ikegami A, Kaneki M, Ouchi Y, Orimo H. Demonstration of isoforms of the estrogen receptor in the bone tissues and in osteoblastic cells. Calcif Tissue Int. 1995;57:466–468. doi: 10.1007/BF00301952. [DOI] [PubMed] [Google Scholar]
  6. Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, Yamamura T. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem. 1997;272:8109–8112. doi: 10.1074/jbc.272.13.8109. [DOI] [PubMed] [Google Scholar]
  7. Ishizuka S, Kurihara N, Hakeda Y, Maeda N, Ikeda K, Kumegawa M, Norman AW. 1α, 25-Dihydroxyvitamin D3[1α, 25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cell. Endocrinology. 1988;123:781–786. doi: 10.1210/endo-123-2-781. [DOI] [PubMed] [Google Scholar]
  8. Kakudo S, Miyazawa K, Kameda T, Mano H, Mori Y, Yuasa T, Nakamaru Y, Shiokawa M, Nagahira K, Tokunaga S, Hakeda Y, Kumegawa M. Isolation of highly riched rabbit osteoclasts from collagen gels: A new assay system for bone resorbing activity of mature osteoclasts. J Bone Miner Metab. 1996;14:129–136. [Google Scholar]
  9. Kaluz S, Kaluzova M, Flint APF. Sequencing variability in the A/B region of the estrogen receptor. Anim Biotechnol. 1997;8:221–226. [Google Scholar]
  10. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997;186:489–495. doi: 10.1084/jem.186.4.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kassem M, Harris SA, Spelsberg TC, Riggs BL. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res. 1996;11:193–199. doi: 10.1002/jbmr.5650110208. [DOI] [PubMed] [Google Scholar]
  12. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T. Congenital osteoclast defi-ciency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med. 1991;173:269–272. doi: 10.1084/jem.173.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Nat Acad Sci USA. 1996;93:5925–5930. doi: 10.1073/pnas.93.12.5925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology. 1997;138:863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
  15. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology. 1997;138:4509–4512. doi: 10.1210/endo.138.10.5575. [DOI] [PubMed] [Google Scholar]
  16. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology. 1995;136:4056–4067. doi: 10.1210/endo.136.9.7649114. [DOI] [PubMed] [Google Scholar]
  17. Rifkin BR. Biology and Physiology of the Osteoclast. Boca Raton: CRC Press; 1993. [Google Scholar]
  18. Saneshige S, Mano H, Tezuka K, Kakudo S, Mori Y, Honda Y, Itabashi A, Yamada T, Miyata K, Hakeda Y, Ishii J, Kumegawa M. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem J. 1995;309:721–724. doi: 10.1042/bj3090721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP β. Mol Cell Biol. 1995;15:4971–4979. doi: 10.1128/mcb.15.9.4971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Takada Y, Kusuda M, Hiura K, Sato T, Mochizuki H, Nagao Y, Tomura M, Yahiro M, Hakeda Y, Kawashima H, Kumegawa M. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Miner. 1992;17:347–359. doi: 10.1016/0169-6009(92)90785-c. [DOI] [PubMed] [Google Scholar]
  21. Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD. Estrogen and raloxifene stimulate transforming growth factor-β 3 gene expression in rat bone: a potential mechanism for estrogen-or raloxifene-mediated bone maintenance. Endocrinology. 1996;137:2075–2084. doi: 10.1210/endo.137.5.8612550. [DOI] [PubMed] [Google Scholar]
  22. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391–396. doi: 10.1038/ng0897-391. [DOI] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES